Zoekresultaten - 10 results
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
viraemic infections from a 2015 (beginning of year) prevalence estimate of 63·6 million (61·8-75·8) infections (0·9% [0·8-1·0] prevalence). By the end of 2020, an estimated 12·9 million (12·5-15·4) people ...
Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia.
Publication Type: Peer reviewed scientific article Authors: Anja De Weggheleire; Irith De Baetselier; An, Sokkab; Sylvie Goletti; Vanessa Suin; Thai, Sopheak; Sven Francque; Tania Crucitti; Lutgarde ...
Epidemiology and genotype 3 subtype dynamics of hepatitis E virus in Belgium, 2010 to 2017.
BackgroundHepatitis E virus (HEV) is an emerging public health concern in high-income countries and can cause acute and chronic hepatitis. Reported numbers of indigenously acquired HEV infection have increased in the ...
Subtype-specific differences in the risk of hospitalisation among patients infected with hepatitis E virus genotype 3 in Belgium, 2010-2018.
(2019) Keywords: hepatitits E Abstract: Some European countries recently reported an increase in hepatitis E virus genotype 3 (HEV-3) of the subtype 3c. No link between HEV-3 subtypes and severity is ...
Distribution of HCV genotypes in Belgium from 2008 to 2015.
a genotyping assay was performed in 2008 were younger than those from 2015. Geographical distribution demonstrates that an important number of genotyped HCV patients live outside the Belgian metropolitan cities. ...
Hepatitis E virus serology and PCR: does the methodology matter?
Viral Hepatitis E Hepatitis E virus Humans Immunoglobulin G Immunoglobulin M polymerase chain reaction Sensitivity and Specificity Serologic Tests Abstract: Hepatitis E virus (HEV) genotype 3 is an ...
Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.
envelope protein 1 (E1) are not fully identified. Here we describe the detailed characterization of a human mAb, designated A6, generated from an HCV genotype 1b infected patient. ELISA results showed ...
Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.
59.1% of those with an unknown injecting status were tested for HCV, compared to 86.5% of the patients who had recently injected and 84.5% of those who had ever injected. 36.8% of the people who had ...
A rat model for hepatitis E virus.
hepatitis, and chronic hepatitis E is increasingly recognized as an important problem in the transplant setting. Nevertheless, the fundamental understanding of the biology of HEV replication is limited and ...
Stable HEV IgG seroprevalence in Belgium between 2006 and 2014.
Hepatitis E Hepatitis E virus Humans Immunoglobulin G Immunoglobulin M Seroepidemiologic Studies Abstract: Recent European studies suggest an emergence of hepatitis E virus (HEV) infection. We evaluated ...